David Liu
44Patents
18h-index
47Co-inventors
81Inventor score
Filing activity: May 14, 1991 → Aug 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6277989A | Quinazoline derivatives as medicaments | Chemistry; Metallurgy | 132 | Expired |
| US6476031B1 | Quinazoline derivatives as medicaments | Chemistry; Metallurgy | 103 | Expired |
| US6184226A | Quinazoline derivatives as inhibitors of P-38 .alpha. | Chemistry; Metallurgy | 84 | Expired |
| US5166133A | Method for inhibing adhesion of white blood cells to endothelial cells | Chemistry; Metallurgy | 58 | Expired |
| US6130235A | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 50 | Expired |
| US5340800A | Peptide medicaments for the treatment of disease | Human Necessities | 49 | Expired |
| US6589954B1 | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 47 | Expired |
| US5898419A | Method and apparatus for scaling a cursor on local computer to have the same size relative to a window on the local computer as another cursor has to another window on a remote computer | Physics | 40 | Expired |
| US6541477B2 | Inhibitors of p38-a kinase | Chemistry; Metallurgy | 33 | Expired |
| US5661059A | Boron penetration to suppress short channel effect in P-channel device | Electricity | 30 | Expired |
| US9518091B2 | A4B7 peptide monomer and dimer antagonists | Human Necessities | 28 | Active |
| US9624268B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 26 | Active |
| US8530404B2 | Compounds and methods for treatment of cancer | Human Necessities | 25 | Active |
| US9809623B2 | α4β7 peptide monomer and dimer antagonists | Human Necessities | 24 | Active |
| US6410540B1 | Inhibitors of p38-&agr;kinase | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6448257B1 | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 22 | Expired |
| US10035824B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| US10023614B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| USD387598S | Housing for automatic drapery drive | General | 17 | Expired |
| US10196424B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 17 | Active |
| US7713986B2 | Compounds and methods for treatment of chemotherapy-induced anemia | Human Necessities | 14 | Active |
| US6340685B1 | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 14 | Expired |
| US10787490B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 13 | Active |
| US10278957B2 | Opioid agonist peptides and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10626146B2 | α4β7 thioether peptide dimer antagonists | Human Necessities | 12 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.